Top Stories
-
Source:
Medscape"[Buprenorphine] is a tremendously powerful medication, saves many lives and prevents overdose, but there is a risk of misuse and diversion, albeit pretty low," says Dr. Francis Levin.
-
The Substance Abuse and Mental Health Services Administration has awarded $32 million to the American Academy of Addiction Psychiatry to address opioid use disorders and stimulant use disorders.
Topic
-
“More than any other provider group, primary care providers offer greater potential for expanding access to buprenorphine treatment,” says Dr. Mark Olfson.
Topic
-
Dr. Edward V. Nunes will serve as one of the directors of Columbia's Center for Healing of Opioid and Other Substance Use Disorders-Enhancing Intervention, Development and Implementation (CHOSEN).
Latest News
-
Source:
ABC NewsJanuary 28, 2020"Our results highlight the critical need to improve buprenorphine treatment services, especially for the youngest with opioid use disorder," Dr. Mark Olfson said.
Topic
-
Source:
UPIJanuary 23, 2020"Our results highlight the critical need to improve buprenorphine treatment services, especially for the youngest with opioid use disorder," Dr. Mark Olfson said.
Topic
- January 21, 2020
National statistics on medication treatment for opioid addiction show that buprenorphrine use is increasing in all age groups except the young.
Topic
-
Source:
MedscapeJanuary 9, 2020"We were surprised to learn that there has been a larger decrease in opioid prescribing to adults with more rather than less severe pain," Dr. Mark Olfson said.
Topic
-
Source:
U.S. NewsDecember 17, 2019"Considering the high risk of suicide after nonfatal opioid overdose, this information could be especially valuable in suicide prevention efforts," Dr. Mark Olfson said.
Topic
-
Source:
Daily MailDecember 17, 2019'It's likely that the increasing use of illicit fentanyl has contributed to the rapid increase in unintentional opioid overdose deaths,' explained Dr Mark Olfson.
Topic
- December 17, 2019
Opioid-related suicides account for only 4% of opioid-related deaths, far below previous estimates of 20% to 30%, a new study from Columbia University has found.
Topic
-
Source:
MedscapeDecember 3, 2019"The rate at which individuals relapsed and overdosed after ending treatment was alarmingly high, suggesting that discontinuing buprenorphine is a life-threatening event," said Dr. Williams.
Topic
- December 2, 2019
People with opioid addiction face a high risk of overdose after ending treatment, even when treated for 18 months, a Columbia study has found.
Topic
- January 25, 2019
Researchers at Columbia have developed a “Cascade of Care” model for treating individuals with opioid use disorder based on lessons learned in the HIV/AIDS field.
Topic
